Clicky

Royalty Pharma plc(RPRX) News

Date Title
Jul 26 If EPS Growth Is Important To You, Royalty Pharma (NASDAQ:RPRX) Presents An Opportunity
Jul 18 Morgan Stanley Raises Royalty Pharma (RPRX) Price Target, Maintains Overweight Rating
Jul 18 Royalty Pharma Declares Third Quarter 2025 Dividend
Jul 17 Royalty Pharma Appoints Carole Ho and Elizabeth Weatherman to the Company’s Board of Directors
Jul 16 Royalty Pharma to Announce Second Quarter 2025 Financial Results on August 6, 2025
Jun 29 Investors in Royalty Pharma (NASDAQ:RPRX) have seen respectable returns of 40% over the past year
Jun 27 5 Revealing Analyst Questions From Royalty Pharma’s Q1 Earnings Call
Jun 24 Royalty Pharma and Revolution Medicines Enter Into Funding Agreements for Up to $2 Billion
Jun 4 Royalty Pharma to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
Jun 2 Royalty Pharma plc (NASDAQ:RPRX) On An Uptrend: Could Fundamentals Be Driving The Stock?
May 8 Royalty Pharma (NASDAQ:RPRX) Posts Q1 Sales In Line With Estimates
May 8 Royalty Pharma Reports First Quarter 2025 Results
May 7 Royalty Pharma (RPRX) Reports Q1: Everything You Need To Know Ahead Of Earnings
Apr 8 Royalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of Directors
Feb 23 Why Royalty Pharma Plc (RPRX) is the Best Performing Pharma Stock So Far in 2025
Feb 12 Royalty Pharma Announces R&D Funding Collaboration With Biogen
Feb 12 Royalty Pharma PLC (RPRX) Q4 2024 Earnings Call Highlights: Strong Financial Performance and ...
Feb 11 Royalty Pharma (NASDAQ:RPRX) Misses Q4 Revenue Estimates
Feb 11 Royalty Pharma Reports Q4 and Full Year 2024 Results
Feb 10 Royalty Pharma Earnings: What To Look For From RPRX